Literature DB >> 35562492

Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia.

Benjamin Podvin1, Hélène Guermouche2, Pauline Roynard2, Laure Goursaud3, Céline Berthon3,4, Mahdi Ouafi5, Elise Fourner5, Nicolas Duployez4,5, Olivier Nibourel5, Catherine Roche-Lestienne4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35562492     DOI： 10.1007/s00277-022-04861-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

Authors:  Ulrike Bacher; Torsten Haferlach; Tamara Alpermann; Melanie Zenger; Andreas Hochhaus; Dietrich W Beelen; Michael Uppenkamp; Mathias Rummel; Wolfgang Kern; Susanne Schnittger; Claudia Haferlach
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

2.  A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript.

Authors:  T Wakayama; Y Maniwa; H Ago; N Kakazu; T Abe
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 3.  Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Authors:  J Gabert; E Beillard; V H J van der Velden; W Bi; D Grimwade; N Pallisgaard; G Barbany; G Cazzaniga; J M Cayuela; H Cavé; F Pane; J L E Aerts; D De Micheli; X Thirion; V Pradel; M González; S Viehmann; M Malec; G Saglio; J J M van Dongen
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 4.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

5.  Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.

Authors:  Giacomo Coltro; Abhishek A Mangaonkar; Terra L Lasho; Christy M Finke; Prateek Pophali; Ryan Carr; Naseema Gangat; Moritz Binder; Animesh Pardanani; Martin Fernandez-Zapico; Keith D Robertson; Alberto Bosi; Nathalie Droin; Alessandro M Vannucchi; Ayalew Tefferi; Anthony Hunter; Eric Padron; Eric Solary; Mrinal M Patnaik
Journal:  Leukemia       Date:  2019-12-13       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.